14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 18 days ( -7.69 % )
Last Price $0.210 0 %
High/ Low $0.210 - $0.210 -9.52%
Chg 7 Days -8.70 % $0.230 $0.210
Chg 30 Days 20.00 % $0.175 $0.210
Chg 12 mos N/A $0.210 $0.210
Trend - 3 mos 22.27 % Width: 24.23 %
Trend - 12 mos -8.40 % Width: 76.19 %
Pred. range - 3 mos $0.233 - $0.289 10.78 % - 37.63 %
Pred. range - 12 mos $0.126 - $0.221 -40.19 % - 5.38 %
Short MA avg 3 mos Sell May 13, 2024 - 5 days
Long MA avg 3 mos Buy Apr 19, 2024 - 21 days
Short/Long MA avg 3 mos Buy Apr 12, 2024 - 26 days
Short MA avg 12 mos Sell May 16, 2024 - 2 days
Long MA avg 12 mos Buy Apr 24, 2024 - 18 days
Short/Long MA avg 12 mos Buy May 02, 2024 - 12 days
Pivot Short Buy May 14, 2024 - 4 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Helix BioPharma Corp.

Helix BioPharma . Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biote... HBP.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT